Stephen K. Brannan, Chief Medical Officer at Karuna Therapeutics, Inc. (KRTX), sold 5,000 shares at $318.33 ($1.6M) on 2024-03-08, disclosed to the SEC on 2024-03-11.
Scheduled sale ($1.6M) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $318.33 | 4,900 | $1.6M | 98.0% |
| 2 | $318.96 | 100 | $32K | 2.0% |
| Total | $318.34 avg | 5,000 | $1.6M | 100% |
| Filing → |
| KRTX | SELL | 2024-01-09 | $4.8M | — | Filing → |
| KRTX | SELL | 2023-12-12 | $4.0M | — | Filing → |
| KRTX | SELL | 2023-11-13 | $1.7M | — | Filing → |